Secondary progressive multiple sclerosis (SPMS)

Active Ingredient: Siponimod

Indication for Siponimod

Siponimod is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.

For this indication, competent medicine agencies globally authorize below treatments:

0.25-2 mg once daily

Route of admnistration

Oral

Defined daily dose

1 - 2 mg

Dosage regimen

From 1 To 2 mg once every day

Loading dose

0.25 mg

Detailed description

Before initiation of treatment, patients must be genotyped for CYP2C9 to determine their CYP2C9 metaboliser status. In patients with a CYP2C9*3*3 genotype, siponimod should not be used.

In patients with a CYP2C9*2*3 or *1*3 genotype, the recommended maintenance dose is 1 mg taken once daily (four tablets of 0.25 mg).

The recommended maintenance dose of siponimod in all other CYP2C9 genotype patients is 2 mg.

Siponimod is taken once daily.

Treatment initiation

Treatment has to be started with a titration pack that lasts for 5 days. Treatment starts with 0.25 mg once daily on days 1 and 2, followed by once-daily doses of 0.5 mg on day 3, 0.75 mg on day 4, and 1.25 mg on day 5, to reach the patient’s prescribed maintenance dose of siponimod starting on day 6 (see table).

During the first 6 days of treatment initiation the recommended daily dose should be taken once daily in the morning with or without food.

Dose titration regimen to reach maintenance dosage:

Titration Titration dose Titration regimen Dose
Day 1 0.25 mg 1 × 0.25 mg TITRATION
Day 2 0.25 mg 1 × 0.25 mg
Day 3 0.5 mg 2 × 0.25 mg
Day 4 0.75 mg 3 × 0.25 mg
Day 5 1.25 mg 5 × 0.25 mg
Day 6 2 mg1 1 × 2 mg1 MAINTENANCE

1 In patients with CYP2C9*2*3 or *1*3 genotype, the recommended maintenance dose is 1 mg taken once daily (4 × 0.25 mg). Additional exposure of 0.25 mg on day 5 does not compromise patient safety.

Missed dose(s) during treatment initiation

During the first 6 days of treatment, if a titration dose is missed on one day treatment needs to be re-initiated with a new titration pack.

Missed dose after day 6

If a dose is missed, the prescribed dose should be taken at the next scheduled time; the next dose should not be doubled.

Re-initiation of maintenance therapy after treatment interruption

If maintenance treatment is interrupted for 4 or more consecutive daily doses, siponimod needs to be re-initiated with a new titration pack.

Dosage considerations

Siponimod is taken with or without food.

Active ingredient

Siponimod

Siponimod is a sphingosine-1-phosphate (S1P) receptor modulator. By acting as a functional antagonist on S1P1 receptors on lymphocytes, siponimod prevents egress from lymph nodes. This reduces the recirculation of T cells into the central nervous system (CNS) to limit central inflammation. Siponimod is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease.

Read more about Siponimod

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.